Treatment of Children With Autism Spectrum Disorders and Epileptiform EEG With Divalproex Sodium
Status:
Withdrawn
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if treatment of epileptiform abnormalities in
children with autism spectrum disorder will improve any behaviors in these children. The
investigators will study a number of different behavioral outcomes including behaviors
related to attention, social communication, repetitive behaviors, maladaptive behaviors,
language, motor and sensory, and sleep. The investigators will use an anticonvulsant
medication called valproic acid (in the form of sodium divalproex).
Phase:
Phase 2
Details
Lead Sponsor:
Boston Children's Hospital Boston Children’s Hospital